-
Product Insights
NewMalabsorption Syndrome – Drugs In Development, 2024
Empower your strategies with our Malabsorption Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Malabsorption syndrome is a digestive disorder that prevents absorption of nutrients from the food through the small intestine, leading to indigestion and malnutrition. It can be caused by food allergies, food intolerances, infections, and digestive diseases. Some types of malabsorption include carbohydrate malabsorption, fat malabsorption, bile acid malabsorption, protein malabsorption, and vitamin, mineral, or trace element malabsorption. Treatments include lifestyle changes, a...
-
Product Insights
NewDiabetic Gastroparesis – Drugs In Development, 2024
Empower your strategies with our Diabetic Gastroparesis – Drugs In Development, 2024 report and make more profitable business decisions. Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels can damage nerves in many parts of the body, including the vagus nerve, which controls contractions of the stomach during digestion. Spasms, abdominal pain, feelings of fullness after a small amount of food, and other symptoms such as nausea and vomiting, reflux, heartburn,...
-
Product Insights
NewCholestasis – Drugs In Development, 2024
Empower your strategies with our Cholestasis – Drugs In Development, 2024 report and make more profitable business decisions. Cholestasis is the slowing or stalling of bile flow from liver. Liver produces bile and delivers it to digestive system through a network of vessels called bile ducts. Bile ducts run through liver (intrahepatic ducts) as well as outside of it (extrahepatic ducts). They connect liver, gallbladder, pancreas and small intestine. Bile that can’t reach your intestines can also cause problems in your...
-
Product Insights
NewPancreatic Diseases – Drugs In Development, 2024
Empower your strategies with our Pancreatic Diseases – Drugs In Development, 2024 report and make more profitable business decisions. Pancreatic diseases encompass a range of conditions that affect the pancreas, a vital organ located behind the stomach. The pancreas plays a crucial role in digestion and hormone regulation by producing enzymes for digestion and hormones like insulin and glucagon that regulate blood sugar levels. The Pancreatic Diseases drugs in development market research report provide comprehensive information on the therapeutics under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-01 in Metastatic Hepatocellular Carcinoma (HCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-01 in Metastatic Hepatocellular Carcinoma (HCC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-01 in Metastatic Hepatocellular Carcinoma (HCC) Drug Details: iNeo-Vac-R01...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-01 in Metastatic Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-01 in Metastatic Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-01 in Metastatic Pancreatic Cancer Drug Details: iNeo-Vac-R01 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-01 in Gastrointestinal Tract Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-01 in Gastrointestinal Tract Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-01 in Gastrointestinal Tract Cancer Drug Details: iNeo-Vac-R01 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-01 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-01 in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-01 in Metastatic Colorectal Cancer Drug Details: iNeo-Vac-R01 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-01 in Metastatic Bile Duct Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-01 in Metastatic Bile Duct Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-01 in Metastatic Bile Duct Cancer Drug Details: iNeo-Vac-R01...